Cargando…

Growth Factor and Th2 Cytokine Signaling Pathways Converge at STAT6 to Promote Arginase Expression in Progressive Experimental Visceral Leishmaniasis

Host arginase 1 (arg1) expression is a significant contributor to the pathogenesis of progressive visceral leishmaniasis (VL), a neglected tropical disease caused by the intracellular protozoan Leishmania donovani. Previously we found that parasite-induced arg1 expression in macrophages was dependen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osorio, E. Yaneth, Travi, Bruno L., da Cruz, Alda M., Saldarriaga, Omar A., Medina, Audrie A., Melby, Peter C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072777/ https://www.ncbi.nlm.nih.gov/pubmed/24967908 http://dx.doi.org/10.1371/journal.ppat.1004165

Ejemplares similares

Progressive Visceral Leishmaniasis Is Driven by Dominant Parasite-induced STAT6 Activation and STAT6-dependent Host Arginase 1 Expression
por: Osorio, E. Yaneth, et al.
Publicado: (2012)

In-situ proliferation contributes to the accumulation of myeloid cells in the spleen during progressive experimental visceral leishmaniasis
por: Osorio, E. Yaneth, et al.
Publicado: (2020)

Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes
por: Espitia, Claudia M, et al.
Publicado: (2014)

Splenic CD4(+) T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression
por: Medina-Colorado, Audrie A., et al.
Publicado: (2017)

Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype
por: Kong, Fanping, et al.
Publicado: (2017)

Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis
por: Espitia, Claudia M, et al.
Publicado: (2010)

Identification of Small Molecule Lead Compounds for Visceral Leishmaniasis Using a Novel Ex Vivo Splenic Explant Model System
por: Osorio, Yaneth, et al.
Publicado: (2011)

Malnutrition-related parasite dissemination from the skin in visceral leishmaniasis is driven by PGE(2)-mediated amplification of CCR7-related trafficking of infected inflammatory monocytes
por: Osorio, E. Yaneth, et al.
Publicado: (2023)

Hematological and Clinical Features Associated with Initial Poor Treatment Outcomes in Visceral Leishmaniasis Patients with and without HIV Coinfection in Gondar, Northwest Ethiopia
por: Ademe, Muluneh, et al.
Publicado: (2023)

Cytokines and Their STATs in Cutaneous and Visceral Leishmaniasis
por: Cummings, Hannah E., et al.
Publicado: (2010)

A secondary wave of neutrophil infiltration causes necrosis and ulceration in lesions of experimental American cutaneous leishmaniasis
por: Peniche, Alex G., et al.
Publicado: (2017)

Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection
por: Takele, Yegnasew, et al.
Publicado: (2013)

Correction: Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection
por: Takele, Yegnasew, et al.
Publicado: (2013)

Efficacy of histamine H1 receptor antagonists azelastine and fexofenadine against cutaneous Leishmania major infection
por: Peniche, Alex G., et al.
Publicado: (2020)

Use of domperidone in canine visceral leishmaniasis: gaps in veterinary knowledge and epidemiological implications
por: Travi, Bruno L, et al.
Publicado: (2018)

Arginase Activity - A Marker of Disease Status in Patients with Visceral Leishmaniasis in Ethiopia
por: Abebe, Tamrat, et al.
Publicado: (2013)

The Malnutrition-Related Increase in Early Visceralization of Leishmania donovani Is Associated with a Reduced Number of Lymph Node Phagocytes and Altered Conduit System Flow
por: Ibrahim, Marwa K., et al.
Publicado: (2013)

Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us
por: Travi, Bruno L., et al.
Publicado: (2018)

Gain-of-function STAT1 mutation and visceral leishmaniasis
por: Lyra, Paula Teixeira, et al.
Publicado: (2022)

Evidence That Lipopolisaccharide May Contribute to the Cytokine Storm and Cellular Activation in Patients with Visceral Leishmaniasis
por: Santos-Oliveira, Joanna R., et al.
Publicado: (2011)

Role of Cytokines in Experimental and Human Visceral Leishmaniasis
por: Samant, Mukesh, et al.
Publicado: (2021)

Inflammatory stimuli alter bone marrow composition and compromise bone health in the malnourished host
por: Osorio, E. Yaneth, et al.
Publicado: (2022)

IL-10 and TGF-β Induced Arginase Expression Contributes to Deficient Nitric Oxide Response in Human Visceral Leishmaniasis
por: Kupani, Manu, et al.
Publicado: (2021)

Visceral Leishmaniasis and HIV Coinfection in Latin America
por: Lindoso, José Angelo, et al.
Publicado: (2014)

Diagnostic performance of a Recombinant Polymerase Amplification Test—Lateral Flow (RPA-LF) for cutaneous leishmaniasis in an endemic setting of Colombia
por: Cossio, Alexandra, et al.
Publicado: (2021)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Age-Related Alteration of Arginase Activity Impacts on Severity of Leishmaniasis
por: Müller, Ingrid, et al.
Publicado: (2008)

Lipopolysaccharide-Induced Cellular Activation May Participate in the Immunopathogenesis of Visceral Leishmaniasis Alone or in HIV Coinfection
por: Santos-Oliveira, Joanna Reis, et al.
Publicado: (2012)

Lower levels of leptin are associated with severity parameters in visceral leishmaniasis patients
por: Fievez, Aline Mireille da Cunha, et al.
Publicado: (2019)

Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
por: Pesce, John T., et al.
Publicado: (2009)

Congenital Visceral Leishmaniasis
por: Boehme, Catharina C., et al.
Publicado: (2006)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

Treatment of Visceral Leishmaniasis
por: Moore, E M, et al.
Publicado: (2010)

Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)

Epidemiology of visceral leishmaniasis
por: Ready, Paul D
Publicado: (2014)

Local Increase of Arginase Activity in Lesions of Patients with Cutaneous Leishmaniasis in Ethiopia
por: Abebe, Tamrat, et al.
Publicado: (2012)

Cytokine profiles amongst Sudanese patients with visceral leishmaniasis and malaria co-infections
por: van den Bogaart, Erika, et al.
Publicado: (2014)

Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region
por: Monge-Maillo, Begoña, et al.
Publicado: (2014)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
por: Mondal, Dinesh, et al.
Publicado: (2019)

Toxoplasma gondii Rhoptry Kinase ROP16 Activates STAT3 and STAT6 Resulting in Cytokine Inhibition and Arginase-1-Dependent Growth Control
por: Butcher, Barbara A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rdgg9io7gf3v2t8v1ksghfob15